Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 52, 2022 - Issue 8: 50th year of the DMDG
352
Views
2
CrossRef citations to date
0
Altmetric
Research Articles

Time matters – in vitro cellular disposition kinetics help rationalizing cellular potency disconnects

, , , , , , , & show all
Pages 878-889 | Received 28 Jul 2022, Accepted 27 Sep 2022, Published online: 20 Dec 2022
 

Abstract

  1. Loss in potency is commonly observed in early drug discovery when moving from biochemical to more complex cellular systems. Among other factors, low permeability is often considered to cause such potency disconnects.

  2. We developed a novel cellular disposition assay in MDCK cells to determine passive uptake clearance (PSinf), cell-to-medium ratios at steady-state (Kp) and the time to reach 90% steady-state (TTSS90) from a single experiment in a high-throughput format.

  3. The assay was validated using 40 marketed drugs, showing a wide distribution of PSinf and Kp values. The parameters generally correlated with transcellular permeability and lipophilicity, while PSinf data revealed better resolution in the high and low permeability ranges compared to traditional permeability data. A linear relationship between the Kp/PSinf ratio and TTSS90 was mathematically derived and experimentally validated, demonstrating the dependency of TTSS90 on the rate and extent of cellular accumulation.

  4. Cellular disposition parameters could explain potency (IC50) disconnects noted for seven Bruton’s tyrosine kinase degrader compounds in a cellular potency assay. In contrast to transcellular permeability, PSinf data enabled identification of the compounds with IC50 disconnects based on their time to reach equilibrium. Overall, the novel assay offers the possibility to address potency disconnects in early drug discovery.

Acknowledgements

The authors wish to acknowledge all Novartis scientists, who have supported this work. Special thanks go to Dallas Bednarczyk, Olivia Ledue, Julia Riede, Patrick Schweigler, Claudio Thoma for scientific input and critical evaluation of the manuscript.

Disclosure statement

All authors apart from S.W. are employees of Novartis, and all hold shares in the company apart from S.W. S.W. was employed by Novartis at the time of the study.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 897.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.